Medacist | 20Ways Winter Hospital 2021 Case Study

Decision-Making for Drug Diversion

CASE STUDY

www.medacist.com

AFFORDABILITY AND FLEXIBILITY

“What put Medacist over the top was that relationships matter,” said Fink. “We were dealing

with conflicting system priorities, and the team at Medacist were willing to work with us.

Their professionalism spoke volumes. We can’t thank them enough for their flexibility.”

The team could see the savings stemming from lessening the time an employee spends in labor-intensive

investigations and reducing expensive medication losses. The tool’s efficiencies make it cost-effective.

Specifically, auditing consistency translates into a data reduction of 70% and labor savings of 30-40

hours per month. RxAuditor Investigate came as one single expense with no additional fees for

hardware, software, or support.

COMPATIBILITY

UofL Health underwent a series of technology reviews and changes across the enterprise in 2020.

Many pharmacy automation platforms didn’t have a monitoring system, or installing one was cost-

prohibitive. IT even looked at building a surveillance system when leadership stepped in and said to

review vendors, and Medacist won the account.

Interfacing with existing systems at UofL Health was a prerequisite. Leadership wanted transparency

and standardization — a packaged solution for other systems, pharmacy automation, electronic

health records (EHR), and time and attendance.

“When it came to integrating with other systems, RxAuditor Investigate was the best-of-breed system

for us,” said Fink. “The configuration with our pharmacy system works seamlessly.”

ANALYTICS

RxAuditor Investigate is powered by Medacist’s Genesis™ analytics platform. This detection engine

powers machine learning algorithms developed to identify diversion through pattern recognition —

confirmed by actual diversion events and enriched by multiple other data sources.

The team has access to role-based configurable dashboards to see an overall snapshot, care area, or

at-risk individual.

INVESTIGATIONS

With RxAuditor Investigate, the previous need to perform time-consuming manual audits is eliminated

by incorporating autonomous diversion auditing by evaluation, scoring, and ranking of risk — thus

reducing false positives and curating a targeted list of at-risk individuals.

“When we conduct investigations, we appoint a nurse dedicated to ensuring each step of our

monitoring cycle is complete,” said Fink. “The nurse also manages the program for controlled

substance compliance.”

If local law enforcement, DEA, or Boards of Pharmacy and Nursing are supporting an investigation at

UofL Health, the team can readily retrieve reports and provide meticulous records for those agencies.

RESULT

The concluding theme is that a high level of accountability occurs at UofL Health regarding drug

diversion. A major reason is because RxAuditor Investigate helps safeguard patients and provides

leadership with accurate information to act on diversion.

The system from Medacist is supporting leaders across the enterprise, streamlining operations to

make the facilities more efficient. The diversion teams now access a comprehensive platform of

analytics and tracking technology, saving time and reducing liability.

After the installation, Medacist conducted an in-service to members of the Drug Diversion Response

Team. Leadership received positive feedback, and the staff was specifically pleased with the

performance and transparency of the system.

“It’s about hiring good people and giving them RxAuditor Investigate to do their job,” Fink said.

“From start to finish, we are ensuring accountability.”

RxAuditor Investigate

met our needs at all

levels and from A to Z.

Medacist had the

stronger record in drug

diversion technology

solutions.”

When it came to

integrating with other

systems, RxAuditor

Investigate was the best

of breed system for us.

The configuration with

our pharmacy system

works seamlessly.”

Robert Fink, Pharm.D., MBA,

FACHE, FASHP, BCNSP, BCPS

Chief Pharmacy Executive

~ UofL Health, Louisville, KY

Robert Fink, Pharm.D., MBA,

FACHE, FASHP, BCNSP, BCPS

Chief Pharmacy Executive

~ UofL Health, Louisville, KY

Made with Publuu - flipbook maker